Co-Diagnostics Inc (CODX)

$2.59 -0.06 (-2.26%)
Market Cap 4.84M
Revenue (ttm) 3.92M
Net Income (ttm) -37.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -960.20%
Debt to Equity Ratio 0.00
Volume 56,746,902
Avg Vol 1,288,438
Day's Range N/A - N/A
Shares Out 2.10M
Stochastic %K 19%
Beta 1.31
Analysts Hold
Price Target $45.00

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 438 1036
Website: co-dx.com
Address:
2401 S. Foothill Dr., Suite D, Salt Lake City, United States
MaxProfitTrades
MaxProfitTrades Mar. 21 at 10:49 PM
$CODX I love trading this company 🍻
0 · Reply
ReversalTrack
ReversalTrack Mar. 21 at 6:40 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $OPEN $BURU $CODX $DRMA hot.
0 · Reply
Antiquarian
Antiquarian Mar. 21 at 4:33 PM
$CODX
0 · Reply
SmallPhish
SmallPhish Mar. 21 at 1:00 PM
$CODX Q4 Earnings Estimate: $130,000. Q4 Estimated Operating Costs = $7,000,000
1 · Reply
Minutiae
Minutiae Mar. 21 at 6:17 AM
$CODX CDC Respiratory Virus Activity Levels Mar. 20, 2026 Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html
0 · Reply
Minutiae
Minutiae Mar. 21 at 6:11 AM
$CODX Mar 20 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Mar. 21 at 6:10 AM
$CODX Mar 20 CODX 56,747,138 volume closing at $2.59. Chart starts shorty after 9:30 am to avoid premarket overwhelming day trade volumes. 318,870 after-hour shares trading at $2.38 to $2.59. CODX shares outstanding is ~2.256 million and today's trade volume greatly exceeds that number in multiples. A lot of short sales likely occurred today. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
NVDAistheSHIZ
NVDAistheSHIZ Mar. 21 at 2:13 AM
$CODX just delist, there are no more shares left
0 · Reply
Donniechen12345
Donniechen12345 Mar. 21 at 12:19 AM
$CODX when it was at $3.40 , donnie said will trash to $2.50 and everyone laughed at me lmao $$$$$ you rookies deserved this smh … $1.85-2.25 monday pre market im sorry … thx for trading :)))$
1 · Reply
BreakoutBullz
BreakoutBullz Mar. 21 at 12:16 AM
🛎️ Trade Recap 🛎️ $ANNA ran 🔥💰🎯 +60% from 4.90 call! $AZTR ran 🔥💰🎯 +58% from .24 call! $ARTL ran 🔥💰🎯 +55% from 6.30 initial call! $MNDR ran 🔥💰🎯 +31% from 1.05 call! $CODX ran 🔥💰🎯 +18% from 3.45 call!
0 · Reply
Latest News on CODX
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 20, 2026, 8:00 AM EDT - 1 day ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

Mar 20, 2026, 7:56 AM EDT - 1 day ago

EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 17, 2026, 9:00 AM EDT - 4 days ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics to Present at Medical Korea 2026

Mar 16, 2026, 9:00 AM EDT - 5 days ago

Co-Diagnostics to Present at Medical Korea 2026

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 12, 2026, 9:00 AM EDT - 9 days ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Mar 10, 2026, 9:00 AM EDT - 11 days ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 9, 2026, 9:00 AM EST - 5 weeks ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 5, 2026, 9:00 AM EST - 6 weeks ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Feb 4, 2026, 9:00 AM EST - 6 weeks ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Jan 12, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Co-Diagnostics Announces Reverse Stock Split

Dec 30, 2025, 9:00 AM EST - 2 months ago

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 29, 2025, 9:00 AM EST - 2 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 18, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 17, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 9, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Dec 8, 2025, 12:36 PM EST - 3 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 20, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 18, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:01 PM EST - 4 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 5, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Nov 3, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 9:00 AM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 30, 2025, 1:57 PM EDT - 5 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 29, 2025, 12:51 PM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 22, 2025, 8:30 AM EDT - 5 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 16, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Oct 13, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 30, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 18, 2025, 5:05 PM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 11, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Sep 9, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 18, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:01 PM EDT - 7 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 31, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Jul 15, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 14, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Apr 29, 2025, 7:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Mar 3, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Feb 24, 2025, 8:18 AM EST - 1 year ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Feb 21, 2025, 4:00 PM EST - 1 year ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Jan 7, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Dec 10, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:01 PM EST - 1 year ago

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Nov 5, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Oct 25, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

MaxProfitTrades
MaxProfitTrades Mar. 21 at 10:49 PM
$CODX I love trading this company 🍻
0 · Reply
ReversalTrack
ReversalTrack Mar. 21 at 6:40 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $OPEN $BURU $CODX $DRMA hot.
0 · Reply
Antiquarian
Antiquarian Mar. 21 at 4:33 PM
$CODX
0 · Reply
SmallPhish
SmallPhish Mar. 21 at 1:00 PM
$CODX Q4 Earnings Estimate: $130,000. Q4 Estimated Operating Costs = $7,000,000
1 · Reply
Minutiae
Minutiae Mar. 21 at 6:17 AM
$CODX CDC Respiratory Virus Activity Levels Mar. 20, 2026 Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html
0 · Reply
Minutiae
Minutiae Mar. 21 at 6:11 AM
$CODX Mar 20 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Mar. 21 at 6:10 AM
$CODX Mar 20 CODX 56,747,138 volume closing at $2.59. Chart starts shorty after 9:30 am to avoid premarket overwhelming day trade volumes. 318,870 after-hour shares trading at $2.38 to $2.59. CODX shares outstanding is ~2.256 million and today's trade volume greatly exceeds that number in multiples. A lot of short sales likely occurred today. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
NVDAistheSHIZ
NVDAistheSHIZ Mar. 21 at 2:13 AM
$CODX just delist, there are no more shares left
0 · Reply
Donniechen12345
Donniechen12345 Mar. 21 at 12:19 AM
$CODX when it was at $3.40 , donnie said will trash to $2.50 and everyone laughed at me lmao $$$$$ you rookies deserved this smh … $1.85-2.25 monday pre market im sorry … thx for trading :)))$
1 · Reply
BreakoutBullz
BreakoutBullz Mar. 21 at 12:16 AM
🛎️ Trade Recap 🛎️ $ANNA ran 🔥💰🎯 +60% from 4.90 call! $AZTR ran 🔥💰🎯 +58% from .24 call! $ARTL ran 🔥💰🎯 +55% from 6.30 initial call! $MNDR ran 🔥💰🎯 +31% from 1.05 call! $CODX ran 🔥💰🎯 +18% from 3.45 call!
0 · Reply
Donniechen12345
Donniechen12345 Mar. 21 at 12:15 AM
$CODX As donnie said after 11am , it will keep falling 99% of the time after 11am lol $$$$ read this like a book :))$$$$$
0 · Reply
GimmeMyMonions
GimmeMyMonions Mar. 21 at 12:13 AM
$CODX this has earnings report on the 31st. Might as well wait on it. And it’s well below its price target currently.
0 · Reply
moneydrip
moneydrip Mar. 21 at 12:13 AM
$CODX everything I touch drips money
0 · Reply
2pumps1dump
2pumps1dump Mar. 21 at 12:00 AM
$CODX see y’all bright and early Monday 🫡 those were the cheapies I was after 😈 more in the tank if you want to play again.
0 · Reply
22Allin
22Allin Mar. 20 at 11:42 PM
$CODX this will get even worst I f regret it that I bought it f it I guess I’ll wait no other choice
0 · Reply
LondonVentures
LondonVentures Mar. 20 at 11:34 PM
$CODX lololololololokolol. To all the new clowns who showed up today predicting the run. Not a fn chance. I just banned all you turds.
1 · Reply
Yebego
Yebego Mar. 20 at 11:09 PM
$CODX
0 · Reply
JamesTek2025
JamesTek2025 Mar. 20 at 11:04 PM
$CODX Gimme $3 or no dice shorty. See you folks on Monday.
1 · Reply
Tetoooo
Tetoooo Mar. 20 at 10:27 PM
$ANNA Today I focused on $CODX, $BIAF, and $SER — three low float momentum stocks made 2k+ https://youtu.be/EHt9c5_do6g?si=qffTz_a8nZnGDcAx
0 · Reply
2pumps1dump
2pumps1dump Mar. 20 at 9:31 PM
$CODX where’s the cheapies Donnie? They must be working OT to get that offering out tonight. Where’s the follow through?! Starting to think you’re the hedge fund intern with no capital, all they gave you was a ST account.
1 · Reply
coolmate25
coolmate25 Mar. 20 at 9:12 PM
$CODX When you elect clowns with ego.
1 · Reply
JamesTek2025
JamesTek2025 Mar. 20 at 9:12 PM
$CODX Pulling phantom shares out their arse to short in the dark pool. Not selling and holding a good amount of shares under $3. Drop it lower and I'll dpuble down.
0 · Reply